Jeff Bezos' personal firm Bezos Expeditions is leading a $72-million investment in artificial intelligence data solutions ...

Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly. So, the natural question for CRISPR Therapeutics (NASDAQ:CRSP) shareholders is whether ...

Shares of CRISPR Therapeutics (NASDAQ:CRSP) can’t seem to catch a break, now down close to 8% year to date and more than 80% ...

The First Trust NASDAQ-100 Equal Weighted ETF (QQEW) was launched on 04/19/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Style Box - Large Cap Growth category ...

The Direxion NASDAQ-100 Equal Weighted Index Shares (QQQE) was launched on 03/21/2012, and is a smart beta exchange traded fund designed to offer broad exposure to the Style Box - Large Cap Growth ...

MGK and AIQ face diverging paths amid NVIDIA risks and rising AI players, highlighting AIQ’s active edge. Read more on MGK ...

CRISPR Therapeutics and Intellia face 2025 volatility, but CRSP’s strong cash and launches make it more attractive than NTLA.

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $38.25, moving +1.38% from the previous trading session.

In challenging markets, investment costs take on even greater importance. This Vanguard fund shines in this respect with its ...

Cathie Wood’s ARK ETFs have made significant moves in the stock market on Wednesday, April 30th, 2025, with Advanced Micro ...

Iovance Biotherapeutics (NASDAQ: IOVA) and CRISPR Therapeutics (NASDAQ: CRSP) are two incredibly innovative biotechs, but ...

Another notable trade was the sale of 67,053 shares of Schrödinger Inc (NASDAQ: SDGR) by the ARKG ETF, valued at $1,726,614.